Clinical Trials Directory

Trials / Completed

CompletedNCT01839266

Prognostic Factors for Acute Pulmonary Embolism in Critically Ill Patients

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
34 Years
Healthy volunteers
Not accepted

Summary

Acute pulmonary embolism (PE) is an important cause of in-hospital mortality and may be rapidly fatal if not diagnosed and treated. Despite recent advances in diagnostic and therapeutic modalities, it is still one of the important causes of hospital mortality. Previous several reports have described the variable outcome of patients with PE with reported mortality rate ranging from 8.1% (stable patients) to 25% (with cardiogenic shock) and 65% (post cardiopulmonary resuscitation). Nevertheless, there are no published studies from Korean hospitals that assessed the outcome of acute PE treated in the hospital with IV unfractionated heparin. We conducted this study to determine the outcome, risk factors, clinical characteristics and demographics of patients with acute PE and to identify possible demographic and clinical factors associated with prognosis.

Conditions

Timeline

Start date
2011-11-01
Primary completion
2012-12-01
Completion
2013-04-01
First posted
2013-04-24
Last updated
2013-04-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01839266. Inclusion in this directory is not an endorsement.